Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.050	-3,4%	Dow	12.119	-2,2%	Euro	1,2432	0,6%
ESt50	2.069	-2,4%	Nas	2.748	-2,8%	Öl	98,82	-2,8%
TDax	730,9	-2,7%	Nikkei	8.440	-1,2%	Gold	1.626	4,2%

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myHome
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden
Historisch	Realtime Push	myNews neu		IR-Daten	Anleihen	handeln

16.05.12	Sorin Group Receives Regulatory Approval to Market Memo 3D(TM) Annuloplasty Ring in Japan
10.05.12	Sorin Group Announces FDA Approval and Commercial Launch of Complete Portfolio of Implantable Heart Device Leads
09.05.12	SORIN GROUP ANNOUNCES PUBLICATION OF FULL CLEAR STUDY RESULTS IN PEER REVIEWED CARDIOLOGY JOURNAL
08.05.12	Sorin Group Announces FDA Approval and Commercial Launch of PARADYM(TM) RF ICDs and CRT-D Implantable Heart Devices
23.04.12	Sorin Group: Solid Start to 2012: Underlying Revenue Growth of 2.8%* in the First Quarter
15.03.12	Sorin Group : Final Results for 2011 Confirm Preliminary Figures Published on February 9, 2012
21.02.12	Sorin Group Announces First Implant in U.S. Study of Stentless Pericardial Aortic Valve
09.02.12	Sorin: Preliminary Results for 2011: Net Profit Increases by 48.5%
31.01.12	Sorin Group Launches a New Complete Portfolio of Pacing, Defibrillation and Left Ventricular Leads
27.01.12	Sorin Group Opens New International Training Center for Healthcare Professionals

05.12.11	Sorin Group Announces CE Mark of INSPIRE(TM) New Family of Adult Oxygenators
28.10.11	Sorin Group: 2011 Third Quarter Results: Net Profit Increase of 48%
20.10.11	Sorin Group Announces the First Enrollment in the ISIS-ICD Clinical Study
17.10.11	Sorin Group Invests in Enopace Biomedical, Early Stage Company Focused on Innovative Solution for Heart Failure Patients
12.10.11	Sorin Group Launches SonR® Sensor Based Cardiac Resynchronization Therapy (CRT) Optimization System (1)
29.07.11	Sorin Group: 2011 Second Quarter Results: 54% Increase in Net Profit
28.07.11	Sorin Group Receives CE Mark Approval for the Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment
19.07.11	Sorin Group Announces Purchase of Estech Cannulae Product Line
24.05.11	Goldfarb Branham Law Firm LLP Seeks to Restore Shareholder Value in Yongye International Through Stockholder Lawsuit
24.05.11	Deutsche Bank and Invesco PowerShares Launch First Leveraged ETNs Linked to U.S. Dollar Index® Futures
24.05.11	Oragenics Announces New President, Chief Executive Officer and Member of the Board of Directors
24.05.11	CVD Equipment Corporation Prices Offering of $8.8 Million of Common Stock
24.05.11	Sorin Group Announces First North American Implant of the Freedom Solo Pericardial Aortic Valve
11.05.11	Sorin Group Initiates Share Buy-Back Program
05.05.11	Sorin Group Receives CE Mark Approval for PARADYM(TM) RF ICDs and CRT-D
02.05.11	Sorin Group Launches the VascuClear(™) Endoscopic Vessel Harvesting System
29.04.11	Sorin Group: 2011 First Quarter Results: Continuous Improvement in Profitability
29.04.11	Travelers Catastrophe Response Team Assists in Tornado Recovery
29.04.11	Sorin Group Announces U.S. Launch of XTRA® Autotransfusion System
17.03.11	Sorin Group Reports Final Results for 2010 and Presents the 2011-2015 Strategic Plan
24.02.11	Sorin Group Invests in MD Start, the First Independent European-Based Medtech Accelerator
21.02.11	Sorin Group Announces the Achievement of a Key Milestone in Aortic Valve Replacement
10.02.11	Sorin: 2010 Preliminary Results: Strong Increase in Profitability and Further Significant Reduction in Net Debt
31.01.11	Sorin Group Receives CE Mark Approval for the Innovative Self-Anchoring Aortic Heart Valve, Percevaltm S
26.10.10	SORIN GROUP ANNOUNCES THIRD QUARTER 2010 RESULTS: CONTINUOUS CASH FLOW EXPANSION AND PROFITABILITY GROWTH
22.10.10	Sorin Group Announces Full and Final Settlement of Investigation by Department of Justice
15.09.10	Sorin Group Announces the Presentation of Perceval S* Self-Anchoring Aortic Heart Valve Clinical Results on First 180 Patients
14.09.10	Sorin Group: Shareholders’ Meeting Approves Management Stock Grant Plan
29.07.10	SORIN GROUP Delivers Solid Results for the First Half Of 2010 And Improves the Guidance for the Full Year
17.06.10	Sorin Group: CLEAR Study Demonstrates Automatic Optimization of CRT with SonR Improves Heart Failure Patients Response Rates

Finanzen.net

Sorin SpaAz Aktie [WKN: A0BLHE / ISIN: IT0003544431]

Hinweis

Newssuche

ALLE Nachrichten zur Sorin SpaAz.

Anzeige

ANZEIGE